It could be the longest wait they’ll ever know. Over 11,000 liver transplants were performed last year in the US, while thousands more patients remained in limbo. Others dropped off the waitlist because they got too sick — and an estimated 2,000 died waiting . Now, a UK-based biotech company aims to make liver transplants — and the long waitlists for them — a thing of the past. Ochre Bio is testing potential therapies for chronic liver disease at a cutting-edge lab in NYC that keeps donated